We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction.
- Authors
Kimmel, Stephen E; Berlin, Jesse A; Reilly, Muredach; Jaskowiak, Jane; Kishel, Lori; Chittams, Jesse; Strom, Brian L
- Abstract
Studies have postulated that cyclooxygenase-2 (COX-2) selective inhibitors affect cardiovascular risk through various mechanisms. Some of these mechanisms could increase risk (for example, inhibition of prostacyclin production), and some could decrease risk (for example, inhibition of inflammation).
- Publication
Annals of internal medicine, 2005, Vol 142, Issue 3, p157
- ISSN
1539-3704
- Publication type
Journal Article
- DOI
10.7326/0003-4819-142-3-200502010-00005